The positive and negative syndrome scale (PANSS) for schizophrenia.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Schizophrenia bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/SCHBUL/13.2.261PMID 3616518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophrenia

  2004cited by this paper
• Reliability and validity of the positive and negative syndrome scale for schizophrenics.

  1988cited by this paper
• Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping

  1987cited by this paper
• An international perspective on assessment of negative and positive symptoms in schizophrenia.

  1987cited by this paper
• L-DOPA in the Treatment of Negative Schizophrenic Symptoms: A Single-Subject Experimental Study

  1986cited by this paper
• Significance of Positive and Negative Syndromes in Chronic Schizophrenia

  1986cited by this paper
• Negative and positive schizophrenic syndromes after the acute phase: a prospective follow-up.

  1986influential reference
• Positive and negative syndromes in schizophrenia as a function of chronicity

  1986cited by this paper
• "Negative symptoms": conceptual and methodological problems.

  1985cited by this paper
• Positive and negative schizophrenic symptoms, attention, and information processing.

  1985cited by this paper
• Negative symptoms: are they indigenous to schizophrenia?

  1985cited by this paper
• A Negative Symptom Rating Scale.

  1985cited by this paper
• Birth seasonality and schizophrenia.

  1985cited by this paper
• Symptomatic and neuropsychological components of defect states.

  1985cited by this paper
• Treatment of negative symptoms.

  1985cited by this paper
• Negative and positive symptoms in schizophrenia and depression: a followup.

  1984cited by this paper
• Positive and negative subtypes in acute schizophrenia.

  1984influential reference
• The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.

  1984cited by this paper
• Intelligence in schizophrenia: meta-analysis of the research.

  1984cited by this paper
• Symptoms and the genetics of schizophrenia: implications for diagnosis.

  1984cited by this paper
• Positive and Negative Syndromes in Chronic Schizophrenic Inpatients

  1984influential reference
• Assessment of negative and positive symptoms in schizophrenia.

  1983cited by this paper
• Infants at risk for psychopathology: offspring of schizophrenic parents.

  1983cited by this paper
• Adverse effects of anticholinergic medication on positive schizophrenic symptoms

  1983cited by this paper
• Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.

  1982cited by this paper
• Negative v positive schizophrenia. Definition and validation.

  1982cited by this paper
• Molecular pathology of schizophrenia: more than one disease process?

  1980cited by this paper
• Positive and Negative Schizophrenic Symptoms and the Role of Dopamine

  1980cited by this paper
• The Disabilities of Chronic Schizophrenia—their Nature and the Factors Contributing to their Development

  1980cited by this paper
• Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model.

  1979cited by this paper
• Cognitive abnormality in schizophrenia: a dual-process model.

  1979cited by this paper
• Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

  1978cited by this paper
• The dementia of dementia praecox

  1978cited by this paper
• The Neuroleptic Hypothesis: Study of the Covariation of Extrapyramidal and Therapeutic Drug Effects

  1978cited by this paper
• "Akinetic depression" in schizophrenia.

  1978cited by this paper
• Therapeutic antagonism between anticholinergics and neuroleptics: possible involvement of cholinergic mechanisms in schizophrenia.

  1978cited by this paper
• Cerebral ventricular size and cognitive impairment in chronic schizophrenia.

  1976cited by this paper
• Akinesia: A Poorly Recognized Drug-Induced Extrapyramidal Behavioral Disorder

  1975cited by this paper
• A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics

  1975cited by this paper
• A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences

  1975cited by this paper
• A Temporal Measure of Attention in Schizophrenia and its Clinical Significance

  1974cited by this paper
• Book Review: The Quick Test (QT): Provisional Manual

  1965cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper
• The Quick Test (QT): Provisional Manual 1 , 2

  1962cited by this paper
• LENGTH OF HOSPITAL STAY AND SCHIZOPHRENIA: A REVIEW OF STATISTICAL STUDIES

  1960cited by this paper
• THE QUICK TEST

  1951cited by this paper
• On Dementia

  1871cited by this paper
• diagnostic and statistical manual of mental disorders,

  year unknowncited by this paper

• A Comparative Analysis of the Levels of Insight Between Elderly and Nonelderly Patients Diagnosed With Schizophrenia.

  2026cites this paper
• Hippocampus in the symptom architecture of schizophrenia spectrum disorders: A network analysis approach.

  2026cites this paper
• Delusion as embodied emotion: a qualitatively driven, multimethod study of first-episode psychosis in the UK.

  2026cites this paper
• Visual cortical functional connectivity alterations and their associations with psychotic symptoms in early-onset bipolar disorder.

  2026cites this paper
• Untargeted 1H NMR-based metabolomics unveils distinct circulating biochemical signatures between treatment-resistant and non-treatment-resistant schizophrenia patients: a pilot study

  2026influential citation
• Short-term outcome of early-onset schizophrenia in a tertiary urban hospital

  2026cites this paper
• Associations between glutamate and cerebral blood flow in treatment-resistant schizophrenia during clozapine treatment.

  2026cites this paper
• Augmented intermittent theta-burst stimulation of the left dorsolateral prefrontal cortex for cognitive dysfunction in stable-phase schizophrenia: protocol for a randomized, double-blind, sham-controlled trial

  2026cites this paper
• Reality monitoring across disorders of reality: Systematic and narrative reviews of dissociation and psychosis.

  2026cites this paper
• Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label Trial.

  2026cites this paper
• fMRI-guided rTMS in the treatment of auditory verbal hallucinations in schizophrenia: a case report

  2026influential citation
• Episodic future thinking intervention in schizophrenia patients: Effects and neural correlates.

  2026cites this paper
• Dysregulated miRNAs and downstream gene expression associated with poor treatment response in first-episode psychosis

  2026influential citation
• Association Between Caffeine Levels and Symptom Profile in Schizophrenia: Results from a Cohort Study in Central Greece.

  2026cites this paper
• Effects of an Agro-Healing Horticultural Intervention on Stress, Self-Esteem, and PANSS Scores in Inpatients with Schizophrenia: A Quasi-Experimental Study

  2026cites this paper
• Prevalence and cognitive correlates of sleep problems in Chinese patients with first-episode drug-naïve schizophrenia

  2026cites this paper
• Validation of the Arabic version of the self-assessment of social cognitive impairments (ACSo) tool among a sample of patients with schizophrenia

  2026cites this paper
• Do early intervention services for psychosis maintain their effects after transition to usual/modular care? A systematic review and meta‐analysis

  2026cites this paper
• Instrumental assessment of psychotic disorders in intellectual developmental disorders and autism with cognitive or major communication issues.

  2026cites this paper
• Social networks and symptomatology in recently hospitalized individuals with schizophrenia-spectrum disorders: A six-month longitudinal study.

  2026cites this paper
• Breaking the Negative Symptom Barrier: A Novel Neuromodulation Strategy Using HD-tDCS Primed iTBS in Schizophrenia.

  2026cites this paper
• Reward-related brain function as an endophenotype in the mood-psychosis spectrum

  2026cites this paper
• Structural co-modulation: An individualized measure of inter-component interactions in source-based morphometry

  2026cites this paper
• Differential Effects of Autistic Traits and Psychotic-Like Experiences on the Interpretation and Inference of Social Intentions.

  2026cites this paper
• MTHFR and MTRR Polymorphisms Predict Sex-Dependent Psychotic Symptom Improvements, Not Metabolic Changes

  2026cites this paper
• Beliefs of delusional intensity about body image or eating-related concerns in individuals with Feeding and Eating Disorders: a systematic review and meta-analysis.

  2026cites this paper
• Disentangling violence in schizophrenia: Interactions between symptom trajectories, conduct disorder, and pharmacotherapy.

  2026cites this paper
• Moderating Role of Cigarette Smoking on the Efficacy of tDCS in the Treatment of Negative and Cognitive Symptoms of Schizophrenia: Results from a Randomized Clinical Trial.

  2026cites this paper
• Facial emotion recognition abilities of individuals with schizophrenia and the influence of parental bonding—An exploratory study in a forensic sample

  2026cites this paper
• Effects of add-on asenapine therapy on sleep in schizophrenia: a case series

  2026cites this paper
• Validation of the Scale of Distinctive Elements in the Drawings of Subjects with Psychotic Symptoms: A Study Protocol.

  2026cites this paper
• Exploring brain structural effects of dopaminergic antagonism and partial agonism in antipsychotic-naïve patients with first-episode psychosis using normative modeling.

  2026cites this paper
• The Long‐Term Follow‐Up TIPP Project: LOFT Study Protocol, a 20‐Year Prospective Study of Early Psychosis Patients

  2026cites this paper
• Delivering culturally adapted family interventions for people with schizophrenia in Indonesia: A feasibility randomised controlled trial and nested process evaluation

  2026cites this paper
• What Does the PANSS Autism Severity Score (PAUSS) Really Measure in Patients With First Episode Psychosis? Critical Considerations.

  2026cites this paper
• Momentary dynamics of inner speech varieties, auditory verbal hallucinations, and affect in schizophrenia spectrum disorders: an experience sampling study

  2026influential citation
• Outcome of first episode and relapsing patients with schizophrenia presenting to a tertiary care hospital in Sri Lanka: A prospective one year follow up study.

  2026cites this paper
• Implicit social animations lead to distinct changes of dopaminergic, corticostriatal and thalamocortical functional connectivity in schizophrenia and bipolar disorder.

  2026cites this paper
• Thyroid dysfunction in elderly first-episode drug-naïve major depressive disorder patients with comorbid dyslipidemia: prevalence, clinical profile and associated factors

  2026cites this paper
• White matter alterations in the corpus callosum and visual cortical regions associated with depressive and psychotic symptoms in early-onset bipolar disorder.

  2026cites this paper
• Relationship between N100 amplitude and T1w/T2w-ratio in the auditory cortex in schizophrenia spectrum disorders.

  2026cites this paper
• Establishment and Validation of Machine Learning Model for Predicting Suicide Risk in Patients with Major Depressive Disorder

  2026cites this paper
• People With Early Psychosis Exhibit Distinct Profiles in Neurocognition, Social Cognition and Cognitive Biases: An Exploratory Cluster Analysis.

  2026cites this paper
• Sexual functioning among spouses of individuals with schizophrenia: A clinical perspective.

  2026cites this paper
• What beneficial effects were maintained following a supervised high intensity interval training intervention among overweight individuals with psychotic disorders?

  2026cites this paper
• Neurocognitive deficits in schizophrenia and polymorphic variants of protein kinase signaling pathway genes: search for associations

  2026cites this paper
• Persistence of autistic symptom differences by severity among individuals at clinical high risk for psychosis and with first-episode psychosis: An 18-month longitudinal follow-up study.

  2026cites this paper
• Small EVs miRNA profiles and their expressions in EVs-depleted plasma as an optimal combination panel for treatment-resistant schizophrenia.

  2026cites this paper
• Mapping the intricate relationship between mental disorders and inflammation: research trends and pharmacological implications.

  2026cites this paper
• Prevalence and associated factors of burden, depression, and anxiety among informal caregivers of individuals with severe mental disorders within the '686 program': a community-based cross-sectional study.

  2026cites this paper
• Factors Associated with Personal Recovery Among Brazilians with Schizophrenia: The Role of Occupational Functioning.

  2026cites this paper
• Retinal and choroidal vascular density alterations in patients with schizophrenia: assessment via optical coherence tomography angiography

  2026cites this paper
• Right orbitofrontal cortex rTMS targets anxiety, not depressive, symptoms in first-episode schizophrenia.

  2026cites this paper
• Cognitive profiles in older adults with psychotic disorders: Results from routine clinical assessments

  2026cites this paper
• Exploration of barriers and facilitators to physical activity in adults with schizophrenia involved in a long-term psychosocial rehabilitation programme: a mixed method study.

  2026cites this paper
• The predictive potential and relationship of peripheral non-enzymatic antioxidants with clinical symptoms in first-episode male adolescent-onset schizophrenia patients.

  2026cites this paper
• Reactive astrocytes and network functional connectivity underlying cognitive symptoms in schizophrenia: a PET and fMRI study.

  2026cites this paper
• The Neurophenomenology of a Self-Induced Transcendental Visionary State: A Case Study.

  2026cites this paper
• The effects of extended early intervention services on clinical and functional outcomes in first-episode psychosis.

  2026cites this paper
• Sex differences in neurocognitive response to metacognitive training in first-episode psychosis: Implications for personalized interventions

  2026cites this paper
• Might autobiographical memory be the best predictor of affective theory of mind in schizophrenia and in the general population?

  2026cites this paper
• Validation of a Traumatic Brain Injury Remediation Programme for Chronic Schizophrenia.

  2026cites this paper
• Resting-state hyper- and hypo-connectivity in early schizophrenia: which tip of the iceberg should we focus on?

  2026cites this paper
• Serum High Mobility Group Box Protein-1 Levels in Schizophrenia During Acute Psychotic Episodes and Remission.

  2026cites this paper
• Negative association between cognitive functioning and antipsychotic D2 receptor occupancy, affinity, and dose after first episode psychosis

  2026cites this paper
• Predictions of different elements of everyday functional outcomes in bipolar disorder and schizophrenia: Cognition, social cognition, clinical symptoms, and mood states as predictors.

  2026cites this paper
• Dopamine synthesis capacity in patients with remitted psychosis: correlates and one year outcome on relapse.

  2026cites this paper
• Quality of Life in Community‐Dwelling Elderly With Severe Mental Illness: Role of Treatment Adherence and Psychiatric Symptomatology

  2026cites this paper
• The Impact of Exercise Interventions on the Network Structure of Psychotic Symptoms: Analysis From Two Clinical Trials

  2026influential citation
• Predictive processing accounts of psychosis: bottom-up or top-down disruptions

  2026cites this paper
• Research on the syntax of EEG microstates: a comprehensive analysis of epilepsy andpsychosis of epilepsy.

  2026cites this paper
• Risperidone reduces individualized morphometric similarity deviation in schizophrenia and associates with cortical transcriptomic patterns

  2026cites this paper
• Abnormal plasma oxidative stress markers in first-episode schizophrenia and associations with clinical symptoms and cognitive function

  2026cites this paper
• Distinct subcortical neuroanatomic profiles of treatment-resistant schizophrenia: structural magnetic resonance imaging study

  2026influential citation
• Jumping to conclusions bias in early psychosis: Relationships with symptom dimensions, neurocognition and social cognition

  2026influential citation
• Psychiatric study of new substance use

  2026cites this paper
• Acupuncture as adjunctive treatment for schizophrenia: a systematic review and meta-analysis.

  2026cites this paper
• The relationship between mental state decoding and real-world social functioning – An experience sampling investigation

  2026influential citation
• The role of cognitive function in predicting metabolic risk in schizophrenia: a multi-model comparison incorporating clinical features

  2026cites this paper
• Circadian rhythm and aggressive behavior in community-dwelling schizophrenia patients testing a moderated mediation model

  2026cites this paper
• Magnetic seizure therapy preserves delayed memory and 40-Hz auditory steady-state responses compared with electroconvulsive therapy in schizophrenia.

  2026cites this paper
• Development of a supportive mHealth device for persons with schizophrenia spectrum disorders (KisoLightApp): a usability study within a participant-involvement principle

  2026cites this paper
• A multimodal fusion analysis of structural and functional abnormalities in acute onset treatment-resistant schizophrenia.

  2026cites this paper
• Altered placental expression of neurotransmitter and stress-related molecules in first-episode psychosis during pregnancy: Implications for cytoarchitecture and function.

  2026cites this paper
• A symptom network approach to schizophrenia in the CATIE study: processing speed as the central cognitive impairment

  2026cites this paper
• Clinical remission, functional recovery, and employment in early-phase schizophrenia treated with paliperidone palmitate: An 18-month longitudinal Asia-Pacific study.

  2026cites this paper
• Predictive Factors of Low HDL-C in Patients with Schizophrenia

  2026cites this paper
• Assessing Usage and Usability of a Narrative-Based Psychoeducational Digital Intervention to Improve Medication Adherence Among Individuals With Schizophrenia in a Stable Phase: Mixed Methods Study

  2026cites this paper
• Relationships between attachment insecurity, beliefs about the self and others, paranoia, and social functioning across the psychosis continuum.

  2026cites this paper
• Disability, quality of life, and family burden in treatment naïve patients with schizophrenia and obsessive-compulsive disorder: A comparative study.

  2026cites this paper
• Association between reduced plasma dopamine β-hydroxylase levels and immediate memory impairment in first-episode drug-naïve schizophrenia.

  2026cites this paper
• Altered auditory seed-based functional connectivity in other specified schizophrenia spectrum and other psychotic disorder compared to schizophrenia spectrum disorders.

  2026cites this paper
• Staff’s Countertransference and Implicit Attitudes Toward Insight in Psychotic Disorders – Do We Prefer Psychotic Patients with Insight?

  2026cites this paper
• Unmet Promise or Missed Potential? A pairwise and network meta-analysis on efficacy and safety of metabotropic glutamate receptor agonists and positive allosteric modulators in schizophrenia.

  2026cites this paper
• Mapping intrinsic brain activity and multilevel mechanisms underlying auditory verbal hallucinations in schizophrenia: A systematic review and meta-analysis.

  2026cites this paper
• High-density lipoprotein (HDL) in older patients with schizophrenia: implications for clinical and cognitive outcomes

  2026cites this paper
• Chemical element profiling in hair of bipolar disorder patients and healthy controls

  2026cites this paper
• Efficacy and long-term effects of intermittent theta burst stimulation on negative symptoms in schizophrenia: a systematic review and meta-analysis

  2026cites this paper
• The Role of Amphiregulin and Epidermal Growth Factor Receptor in First-Episode Psychosis: Exploring Links to Schizophrenia Pathophysiology.

  2026cites this paper
• Biological underpinnings and genetic predisposition to schizophrenia within microrna-137 regulatory pathways across brain development

  2026cites this paper